ESC 365 - Genome engineering of iPS-derived cardiomyocytes.

ESC Premium Access

Genome engineering of iPS-derived cardiomyocytes.

Session: Should we modify the genome to cure cardiovascular disease?

Topic: Genetics and gene therapy

Speaker: Doctor R. Hajjar (Boston, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Roger J Hajjar

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)

5 presentations

0 follower

2 more presentations in this session

Genome editing of familial cardiomyopathy

Speaker: Professor J. Hulot (Paris, FR)

Molecular strategies to treat cardiac arrhythmias

Speaker: Professor S. Priori (Pavia, IT)

Access the full session

Should we modify the genome to cure cardiovascular disease?

Speakers: Doctor R. Hajjar, Professor J. Hulot, Professor S. Priori

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources